Societal CDMO(REPH)

2.09 0.00 0.0%

今开:0.0昨收:2.09
最高:0.0 最低:0.0
涨停价:0.0跌停价:0.0
总市值:1.17926555E8

Societal CDMO的最新讨论

风之驹2020-11-27 22:42

$Recro制药(REPH)$稳定上调,快 要开始飞了查看全文

牛唐2019-03-18 17:34

$Recro制药(REPH)$ 的N1539治疗术后疼痛在去年吃了CRL,主要原因是数据及次要终点的选择不符合FDA的预期,这个月24号第二次申请,过的概率有,但不会很大查看全文

usbiostock2018-05-25 09:14

$Recro Pharma, Inc. (REPH)$ FDA拒绝批准IV meloxicam,认为其止痛效果未能达到FDA预期。查看全文

32hits2018-05-24 20:56

$Recro Pharma, Inc. (REPH)$ 死了,操查看全文

32hits2016-12-06 21:48

$Recro Pharma(REPH)$ 盘前怎么回事查看全文

44美分2016-11-28 21:53

$Recro Pharma(REPH)$ 现在的市场啊,见到三期不错的就跟打了鸡血一样。。。查看全文

32hits2015-06-19 00:01

$Recro Pharma(REPH)$ 卖早了[哭泣]查看全文

32hits2015-06-04 22:49

$Recro Pharma(REPH)$ 这几天量明显加大了查看全文

32hits2015-06-03 22:19

$Recro Pharma(REPH)$ 快到上车的时候了查看全文

1 2

Societal CDMO的公告

超过5%股东持股披露「修订」

$Recro制药(REPH)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001535264-22-000011  Act: 34  Size: 9 KB 网页链接

超过5%股东持股披露「修订」

$Recro制药(REPH)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-22-020287  Act: 34  Size: 61 KB 网页链接

超过5%股东持股披露「修订」

$Recro制药(REPH)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001037389-22-000087  Act: 34  Size: 13 KB 网页链接

生效批准

$Recro制药(REPH)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-22-000390  Act: 33  Size: 1 KB 网页链接

超过5%股东持股披露「修订」

$Recro制药(REPH)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000919574-22-000705  Act: 34  Size: 112 KB 网页链接

持股变动声明

$Recro制药(REPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-22-002640  Size: 4 KB 网页链接

持股变动声明

$Recro制药(REPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-004168  Size: 4 KB 网页链接

持股变动声明

$Recro制药(REPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-003084  Size: 8 KB 网页链接

持股变动声明

$Recro制药(REPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-003083  Size: 8 KB 网页链接

当期报告

$Recro制药(REPH)$ 8-K Current report, item 5.02 Accession Number: 0000950170-22-000448  Act: 34  Size: 157 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48